2021-001 Yan'an Pharmaceutical: Resignation of Directors and Senior Management
classification: Notice
Time:2021-03-02 10:41
1. The basic situation of resigning directors, supervisors and senior executives
(1) Basic information
The board of directors of the company received the resignation report from director Mr. Su Hongming on January 4, 2021, and the resignation will take effect on January 4, 2021. The above-mentioned resigners hold 784,000 shares of the company, accounting for 0.6222% of the company's share capital. He is not a target of joint punishment for dishonesty, and will no longer hold other positions in the company after resigning.
The board of directors of the company received the resignation report from the secretary of the board of directors Mr. Su Hongming on January 4, 2021, and the resignation will take effect on January 4, 2021. The above-mentioned resigners hold 784,000 shares of the company, accounting for 0.6222% of the company's share capital. He is not a target of joint punishment for dishonesty, and will no longer hold other positions in the company after resigning.
The board of directors of the company received the resignation report submitted by Mr. Su Hongming from other positions on January 4, 2021, and the resignation will take effect on January 4, 2021. The above-mentioned resigners hold 784,000 shares of the company, accounting for 0.6222% of the company's share capital. He is not a target of joint punishment for dishonesty, and will no longer hold other positions in the company after resigning.
The board of directors of the company received the resignation report from Mr. Su Hongming, the person in charge of information disclosure, on January 4, 2021, and the resignation will take effect on January 4, 2021. The above-mentioned resigners hold 784,000 shares of the company, accounting for 0.6222% of the company's share capital. He is not a target of joint punishment for dishonesty, and will no longer hold other positions in the company after resigning.
Does the resignation of the directors and supervisors involve changes in the secretary of the board of directors: Yes
(2) Reasons for resignation
Mr. Su Hongming resigned from the company's director, secretary of the board of directors, and other positions (assistant to the general manager) due to personal reasons.
2. The impact of the resignation of the above-mentioned personnel on the company
(1) This resignation did not cause the number of members of the company's board of directors to fall below the statutory minimum, and did not cause the number of members of the company's board of supervisors to fall below the statutory minimum.
(2) Impact on the company's production and operation
After Mr. Su Hongming resigns as the secretary of the board of directors, Ms. Zhao Junling, the person in charge of the company's finance, will temporarily replace the secretary of the board of directors and other positions (assistant to the general manager). The company will arrange for director by-election as soon as possible. The resignation of Mr. Su Hongming has not had a significant adverse impact on the company's daily operating activities and will not affect the normal operation of the board of directors.
3. Documents for reference
1. Resignation report
Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
January 4, 2021